Outcomes of the Medacta Shoulder System for Various Shoulder Conditions Including Osteoarthritis and Rotator Cuff Tear Arthropathy

What this Trial Is About

Researchers are observing clinical and radiological outcomes of the Medacta Shoulder System in patients with various shoulder conditions including primary and secondary osteoarthritis, rotator cuff tear arthropathy, rheumatoid arthritis, avascular necrosis, fractures, and revision of shoulder arthroplasty. This post-marketing surveillance study evaluates how well the system performs over time in real-world settings. The study involves monitoring patients who have received the Medacta Shoulder System implant. Outcomes assessed include implant survival rate up to 10 years, clinical and functional shoulder scores at 1, 2, 5, and 10 years, radiographic evaluations for implant positioning and signs of loosening, patient quality of life, and any adverse events related to the implant. Participants will be followed for up to 10 years with scheduled assessments including clinical exams, shoulder function scoring, imaging studies, and patient questionnaires. Researchers will track the implants durability and patient health over time to understand long-term outcomes and safety. The total participation period can last a decade to capture comprehensive data.

Clinical and Radiological Outcomes of Medacta Shoulder System FR